TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2780120

Group type: EXPERIMENTAL
Intervention: Exclusion of cow's milk from diet
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control diet containing cow's milk
Number of subjects: 146
Study: 776197

Group type: EXPERIMENTAL
Intervention: Subanaesthetic incremental doses of Althesin
Number of subjects: 61

Group type: COMPARATOR
Intervention: Single sedative dose of diazepam
Number of subjects: 61
Study: 30641027

Group type: EXPERIMENTAL
Intervention: Indacaterol/Glycopyrronium (IND/GLY) 110/50 μg once daily for 14 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 27609399

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 25593053

Group type: EXPERIMENTAL
Intervention: Transendocardial stem cell injection (TESI) using culture‐expanded mesenchymal stem cells (MSCs)
Number of subjects: 49
Study: 23748315

Group type: EXPERIMENTAL
Intervention: Ball attachments
Number of subjects: 29

Group type: COMPARATOR
Intervention: Locator attachments
Number of subjects: 29
Study: 21459735

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 19527481

Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart (BIAsp) three times a day (70/30 high-mix before breakfast and lunch, 30/70 before dinner)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart (BIAsp) three times a day
Number of subjects: 38

Group type: COMPARATOR
Intervention: Biphasic human insulin (BHI) 30/70 twice a day
Number of subjects: 38
Study: 16750467

Group type: EXPERIMENTAL
Intervention: Remifentanil 1 microg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sufentanil 0.25 microg/kg
Number of subjects: 60
Study: 14993632

Group type: EXPERIMENTAL
Intervention: Multi-dose DEC (6 mg/kg) and Alb (400 mg) for seven days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-dose DEC and Alb
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Re-treatment with single-dose DEC/Alb 12 months after first treatment
Number of subjects: 0
Study: 11207085

Group type: EXPERIMENTAL
Intervention: 3.4 g of omega-3 fatty acids daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 9310046

Group type: EXPERIMENTAL
Intervention: Intramedullary cemented massive allografts
Number of subjects: 45

Group type: COMPARATOR
Intervention: Uncemented allografts
Number of subjects: 45
Study: 8422853

Group type: EXPERIMENTAL
Intervention: Carbamazepine 600 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Carbamazepine 400 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lamotrigine 300 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3009634

Group type: EXPERIMENTAL
Intervention: RRV-1 vaccine
Number of subjects: 48

Group type: COMPARATOR
Intervention: RIT 4237 vaccine
Number of subjects: 48
Study: 29858113

Group type: EXPERIMENTAL
Intervention: Tight-control treatment aiming at SDAI ≤ 3.3
Number of subjects: 80

Group type: COMPARATOR
Intervention: Tight-control treatment aiming at DAS28-CRP < 2.6
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Not achieving sustained SDAI remission at month 6, 9, and 12
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Rheumatoid factor >16U
Number of subjects: 80
Study: 27487966

Group type: EXPERIMENTAL
Intervention: Nurse-initiated antiviral therapy with pegylated interferon and ribavirin
Number of subjects: 138

Group type: COMPARATOR
Intervention: Physician-initiated antiviral therapy with pegylated interferon and ribavirin
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Nurse-initiated antiviral therapy
Number of subjects: 138

Group type: COMPARATOR
Intervention: Physician-initiated antiviral therapy
Number of subjects: 138
Study: 24759852

Group type: EXPERIMENTAL
Intervention: Family-based cognitive behavior therapy (FB-CBT) including exposure plus response prevention
Number of subjects: 127

Group type: COMPARATOR
Intervention: FB relaxation treatment (FB-RT)
Number of subjects: 127
Study: 21969123

Group type: EXPERIMENTAL
Intervention: 7 mg transdermal nicotine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 20 mg oral mecamylamine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 20214326

Group type: EXPERIMENTAL
Intervention: Wuzi Yanzong Decoction (WYD) plus coenzyme Q10
Number of subjects: 30

Group type: COMPARATOR
Intervention: Coenzyme Q10 alone
Number of subjects: 30
Study: 17553503

Group type: EXPERIMENTAL
Intervention: Massaging with dimethyl sulfoxide (DMSO) cream
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Massaging with an indifferent cream
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Position changes only
Number of subjects: 0
Study: 15483541

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 11560018

Group type: EXPERIMENTAL
Intervention: Combination of atenolol and enalapril maleate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of atenolol, enalapril maleate, and hydrochlorothiazide
Number of subjects: 0
Study: 10198825

Group type: EXPERIMENTAL
Intervention: Alzheimer's disease group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-demented patients with beta A4 plaques
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-demented patients without evidence of frontal plaques
Number of subjects: 0
Study: 8167121

Group type: EXPERIMENTAL
Intervention: University of Wisconsin solution
Number of subjects: 10

Group type: COMPARATOR
Intervention: Buffered cold cardioplegic solution
Number of subjects: 10
Study: 3172641

Group type: EXPERIMENTAL
Intervention: Polysulfone dialyzer (Fresenius F-80)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cuprophane dialyzer (Travenol 12.11)
Number of subjects: 0

Group type: COMPARATOR
Intervention: F-40 dialyzer
Number of subjects: 0

Group type: COMPARATOR
Intervention: F-60 dialyzer
Number of subjects: 0
Study: 6449205

Group type: COMPARATOR
Intervention: 1 g mezlocillin/oxacillin (20% solution) injected intramuscularly
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1.5 g mezlocillin/oxacillin (25% aqueous solution) injected intramuscularly t.i.d. for about 7 days
Number of subjects: 20
Study: 31641754

Group type: EXPERIMENTAL
Intervention: Single dose of ivermectin, diethylcarbamazine, and albendazole (IDA)
Number of subjects: 95

Group type: COMPARATOR
Intervention: 3 annual doses of ivermectin and albendazole (IA)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Single dose of IDA
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 95
Study: 30182455

Group type: EXPERIMENTAL
Intervention: Structured nursing intervention program for 10 days
Number of subjects: 216

Group type: COMPARATOR
Intervention: Existing practice nursing care
Number of subjects: 216
Study: 28125621

Group type: EXPERIMENTAL
Intervention: Treatment group (viewing a video featuring individuals living in extreme poverty)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 26555225

Group type: EXPERIMENTAL
Intervention: Far-Infrared (FIR) intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Near-Infrared Spectroscopy (NIRS) measurement
Number of subjects: 0
Study: 23313835

Group type: EXPERIMENTAL
Intervention: Feedback delay of 500ms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stimulus present throughout feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Large variance (SD=150ms) in feedback delay times around a mean delay of 500ms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Small variance (SD=75ms) in feedback delay times around a mean delay of 500ms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delay between stimulus offset and feedback
Number of subjects: 0
Study: 21120562

Group type: EXPERIMENTAL
Intervention: 5 mCi Yttrium-90 plus 40 mg of triamcinolone hexacetonide (Y/TH Group)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 15 mCi Samarium-153 hydroxyapatite plus 40 mg of triamcinolone hexacetonide (Sm/TH Group)
Number of subjects: 84

Group type: COMPARATOR
Intervention: 40 mg triamcinolone hexacetonide alone (Control Group)
Number of subjects: 84
Study: 19668094

Group type: EXPERIMENTAL
Intervention: Captain's Log cognitive training software (8 weeks, weekly sessions)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Nontreatment condition
Number of subjects: 65
Study: 17500180

Group type: EXPERIMENTAL
Intervention: Transfixed stitches technique
Number of subjects: 160

Group type: COMPARATOR
Intervention: Milligan‐Morgan procedure
Number of subjects: 160
Study: 15259080

Group type: EXPERIMENTAL
Intervention: Plasma exchange (Group A)
Number of subjects: 94

Group type: COMPARATOR
Intervention: No plasma exchange (Group B)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Group I (before plasma exchange availability)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Group II (after plasma exchange availability)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Severe hyperlipidemic pancreatitis patients receiving plasma exchange (Group A)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Severe hyperlipidemic pancreatitis patients not receiving plasma exchange (Group B)
Number of subjects: 94
Study: 11136308

Group type: EXPERIMENTAL
Intervention: Needlescopic cholecystectomy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy
Number of subjects: 75
Study: 10048504

Group type: EXPERIMENTAL
Intervention: Irbesartan 75 mg once daily (doubled at week 6 if seated diastolic blood pressure >= 90 mmHg)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Placebo/HCTZ
Number of subjects: 238
Study: 8055388

Group type: EXPERIMENTAL
Intervention: Scopolamine
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 2923821

Group type: EXPERIMENTAL
Intervention: Acetone at 250 ppm
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Ethanol (95%‐0.84 ml/kg)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Methyl ethyl ketone (MEK) at 200 ppm
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Acetone at 125 ppm with MEK at 100 ppm
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Combined acetone/MEK exposures
Number of subjects: 137
Study: 1053438

Group type: EXPERIMENTAL
Intervention: Betamethasone valerate nasal aerosol (400 micrograms daily)
Number of subjects: 103
Study: 30711003

Group type: EXPERIMENTAL
Intervention: Neck-specific exercise intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study: 29033138

Group type: EXPERIMENTAL
Intervention: Escitalopram (20 mg daily) - overt group
Number of subjects: 46

Group type: COMPARATOR
Intervention: Escitalopram (20 mg daily) - covert group
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Escitalopram (20 mg daily) - both groups
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: fMRI outcomes - both groups
Number of subjects: 46
Study: 25528758

Group type: EXPERIMENTAL
Intervention: Second generation antipsychotics
Number of subjects: 5233
Study: 22703472

Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 9

Group type: COMPARATOR
Intervention: Irbesartan, Valsartan, Candesartan
Number of subjects: 9
Study: 22098139

Group type: EXPERIMENTAL
Intervention: Triflusal EC
Number of subjects: 38

Group type: COMPARATOR
Intervention: Triflusal
Number of subjects: 38
Study: 20058592

Group type: EXPERIMENTAL
Intervention: Intradiscal methylene blue (MB) injection
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 72
Study: 17264356

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (vacuum-assisted closure)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline gauze dressings
Number of subjects: 0
Study: 14716710

Group type: EXPERIMENTAL
Intervention: Quetiapine plus nizatidine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Quetiapine plus placebo
Number of subjects: 28
Study: 11529631

Group type: EXPERIMENTAL
Intervention: 99mTc NC scintigraphy
Number of subjects: 51
Study: 10101560

Group type: COMPARATOR
Intervention: Standard second reminder letter (R)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Standard second reminder letter with health education material (RP)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Standard second reminder letter with home visit (RV)
Number of subjects: 1500
Study: 8169676

Group type: EXPERIMENTAL
Intervention: Discharge teaching and home care in the first 4 weeks after discharge
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Maternal acute care visits
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Infant rehospitalizations
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Infant acute care visits
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Maternal rehospitalizations
Number of subjects: 245
Study: 3356049

Group type: COMPARATOR
Intervention: Continuous infusion of epidural bupivacaine-fentanyl (initial dose of 5-7 ml, continuous infusion of 3 ml/h)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Repeated injections of epidural bupivacaine-fentanyl (initial dose ranged from 8-12 ml)
Number of subjects: 44
Study: 29434529

Group type: EXPERIMENTAL
Intervention: High-protein diet (≥2.2 g/kg/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control diet (habitual diet)
Number of subjects: 24
Study: 28299944

Group type: EXPERIMENTAL
Intervention: ST-fermented milk
Number of subjects: 59

Group type: COMPARATOR
Intervention: Non-fermented placebo milk (PC)
Number of subjects: 59
Study: 26625880

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 893

Group type: COMPARATOR
Intervention: Pravastatin 40 mg/day
Number of subjects: 893
Study: 24260218

Group type: EXPERIMENTAL
Intervention: BCI training system (8-week training comprising 24 half-hour sessions)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: BCI training system
Number of subjects: 31

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 31
Study: 21420316

Group type: EXPERIMENTAL
Intervention: Dietary counseling paired with personal digital assistant-based self-monitoring in hemodialysis (HD) patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary counseling paired with personal digital assistant-based self-monitoring in peritoneal dialysis (PD) patients
Number of subjects: 0
Study: 18481712

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) combined with acupoint-injection (adenosine cobaltamine)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Acupuncture (simple acupuncture)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) combined with acupoint-injection
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment within 1 month after operation
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment within 2 weeks after attack
Number of subjects: 78
Study: 17702710

Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 3800

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3800
Study: 14637261

Group type: EXPERIMENTAL
Intervention: Conventional therapy + atorvastatin (10 mg/day), Group B
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional therapy, Group A
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Atorvastatin (in vitro, 0.1-10 micromol/l)
Number of subjects: 40
Study: 10718567

Group type: EXPERIMENTAL
Intervention: Implicit learning (concurrent secondary tone-counting task)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Explicit learning (without secondary task)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delayed retention test
Number of subjects: 0
Study: 9019176

Group type: EXPERIMENTAL
Intervention: Rabbit-position with PEEP 0 cm H2O
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Rabbit-position with PEEP 10 cm H2O
Number of subjects: 34

Group type: COMPARATOR
Intervention: Supine position with PEEP 0 cm H2O
Number of subjects: 34

Group type: COMPARATOR
Intervention: Supine position with PEEP 10 cm H2O
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups with rising PEEP
Number of subjects: 34
Study: 8258205

Group type: EXPERIMENTAL
Intervention: Amoxicillin 40 mg/kg/day for 10 days (Group I: one total dose of amoxicillin and two doses of placebo daily)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Amoxicillin 40 mg/kg/day for 10 days (Group II: three divided doses of amoxicillin daily)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Both groups (Group I and Group II)
Number of subjects: 77
Study: 3896354

Group type: EXPERIMENTAL
Intervention: Masker treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with no instrumental treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hearing aid or combination instrument treatment
Number of subjects: 0
Study: 31629573

Group type: EXPERIMENTAL
Intervention: enalapril, 10mg, and folic acid, 0.8mg
Number of subjects: 1374

Group type: COMPARATOR
Intervention: enalapril, 10mg alone
Number of subjects: 1374
Study: 30238061

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing + Enhanced Community Services (MI + ECS)
Number of subjects: 579

Group type: COMPARATOR
Intervention: Enhanced Community Services (ECS)
Number of subjects: 579
Study: 26089210

Group type: EXPERIMENTAL
Intervention: Active supplement (novel, multi-component formula containing xanthophyll pigments, antioxidants and selected botanical extracts)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active supplement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24491793

Group type: EXPERIMENTAL
Intervention: Stepped wedge design intervention
Number of subjects: 0
Study: 23131884

Group type: EXPERIMENTAL
Intervention: Acamprosate (2000 mg/d)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 20657852

Group type: EXPERIMENTAL
Intervention: Piezoelectric technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional surgical technique
Number of subjects: 40
Study: 18490667

Group type: EXPERIMENTAL
Intervention: Sequential therapy
Number of subjects: 2747

Group type: COMPARATOR
Intervention: Standard triple therapy
Number of subjects: 2747
Study: 16018747

Group type: EXPERIMENTAL
Intervention: Surgical periodontal therapy
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 14
Study: 12426517

Group type: EXPERIMENTAL
Intervention: Nasal methadone (10 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intravenous methadone (10 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral methadone (10 mg)
Number of subjects: 8
Study: 10557507

Group type: EXPERIMENTAL
Intervention: Worksite-level interventions for smoking and health-related outcomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjustment for individual-level characteristics
Number of subjects: 0
Study: 8765442

Group type: EXPERIMENTAL
Intervention: High-dose ondansetron
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ondansetron plus metoclopramide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-dose ondansetron
Number of subjects: 0
Study: 1834161

Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg loading dose; A: 4 mg i.v. + 4 mg orally; B: 8 mg i.v.), followed by oral treatment for 5 days (A: 6‐hourly; B: 8 mg 8‐hourly)
Number of subjects: 35
Study: 6349653

Group type: EXPERIMENTAL
Intervention: Meclofenamate sodium (200 mg/day for 1 week, 250 mg/day for 2nd week, 300 mg/day for 3rd to 8th week)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Indometacin (100 mg/day for 1 week, 125 mg/day for 2nd week, 150 mg/day for 3rd to 8th week)
Number of subjects: 98
Study: 30773608

Group type: EXPERIMENTAL
Intervention: Standard Positive Birth After Caesarean care plus a decision aid booklet
Number of subjects: 297

Group type: COMPARATOR
Intervention: Standard Positive Birth After Caesarean care
Number of subjects: 297
Study: 30158029

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine injection (20 ml) at port sites
Number of subjects: 120

Group type: COMPARATOR
Intervention: No bupivacaine injection
Number of subjects: 120
Study: 26871297

Group type: EXPERIMENTAL
Intervention: Extended-release guanfacine hydrochloride (GXR)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 528
Study: 25024031

Group type: EXPERIMENTAL
Intervention: MRI-based patient-specific instrumentation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CT-based patient-specific instrumentation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional instrumentation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MRI-based vs CT-based patient-specific instrumentation
Number of subjects: 90

Group type: COMPARATOR
Intervention: MRI-based and CT-based patient-specific instrumentation vs Conventional instrumentation
Number of subjects: 90
Study: 22830389

Group type: EXPERIMENTAL
Intervention: MTX 25 mg once weekly
Number of subjects: 60

Group type: COMPARATOR
Intervention: MTX 10 mg once weekly
Number of subjects: 60
Study: 20832994

Group type: EXPERIMENTAL
Intervention: Nicorandil (bolus injection of 100 μg/kg, continuous injection of 60‐100 μg/kg/h for 5 days)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no nicorandil)
Number of subjects: 31
Study: 17369799

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20 g day(‐1) of creatine monohydrate for 21 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Maltodextrin placebo
Number of subjects: 16
Study: 16379507

Group type: EXPERIMENTAL
Intervention: risperidone (0.5-3.5 mg/day)
Number of subjects: 101

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 101
Study: 12462385

Group type: EXPERIMENTAL
Intervention: Facilitated referral from screening to diagnostic breast imaging
Number of subjects: 1578

Group type: COMPARATOR
Intervention: Pilot project initiatives
Number of subjects: 1578

Group type: EXPERIMENTAL
Intervention: Biopsied women
Number of subjects: 1578

Group type: EXPERIMENTAL
Intervention: Shortened time to diagnosis
Number of subjects: 1578
Study: 10051720

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (SIT) with HDM extract (Alavac, Bencard) for 2 years
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no SIT)
Number of subjects: 26